Glucuronidation genotypes and nicotine metabolic phenotypes: importance of functional UGT2B10 and UGT2B17 polymorphisms
about
The effect of UGT1A and UGT2B polymorphisms on colorectal cancer risk: haplotype associations and gene–environment interactions.Nicotine N-glucuronidation relative to N-oxidation and C-oxidation and UGT2B10 genotype in five ethnic/racial groups.Variation in trans-3'-hydroxycotinine glucuronidation does not alter the nicotine metabolite ratio or nicotine intake.The contribution of common genetic variation to nicotine and cotinine glucuronidation in multiple ethnic/racial populationsUGT1A and UGT2B genetic variation alters nicotine and nitrosamine glucuronidation in european and african american smokers.Nicotine exposure and metabolizer phenotypes from analysis of urinary nicotine and its 15 metabolites by LC-MS.Homozygous deletions of UGT2B17 modifies effects of smoking on TP53-mutations and relapse of head and neck carcinomaSimultaneous quantification of nicotine and metabolites in rat brain by liquid chromatography-tandem mass spectrometry.Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer PatientsGlucuronidation of trans-3'-hydroxycotinine by UGT2B17 and UGT2B10.Unique β-Glucuronidase Locus in Gut Microbiomes of Crohn's Disease Patients and Unaffected First-Degree RelativesGlucuronides in the gut: Sugar-driven symbioses between microbe and host.Genome-Wide Meta-Analysis of Cotinine Levels in Cigarette Smokers Identifies Locus at 4q13.2.Impact of UGT2B17 Gene Deletion on the Pharmacokinetics of 17-Hydroexemestane in Healthy VolunteersComparison of Puff Volume With Cigarettes per Day in Predicting Nicotine Uptake Among Daily Smokers.Genome-Wide Association of the Laboratory-Based Nicotine Metabolite Ratio in Three Ancestries.Association between Glucuronidation Genotypes and Urinary NNAL Metabolic Phenotypes in Smokers.Regulation of UDP-glucuronosyltransferase 1A1 expression and activity by microRNA 491-3p.UGT2B gene expression analysis in multiple tobacco carcinogen-targeted tissues.Correlation between Cigarette Smoking and Urine Cotinine Level in Gastric Cancer Patients.Transcriptional regulation of human UDP-glucuronosyltransferase genes.To quit or not: Vulnerability of women to smoking tobacco.Role of the UGT2B17 deletion in exemestane pharmacogenetics.Effect of UGT2B10, UGT2B17, FMO3, and OCT2 genetic variation on nicotine and cotinine pharmacokinetics and smoking in African Americans.Detoxification and elimination of nicotine by nectar-feeding birds.Sex/Gender Differences in Cotinine Levels Among Daily Smokers in the Pennsylvania Adult Smoking Study.Relationship between cotinine and trans-3′-hydroxycotinine glucuronidation and the nicotine metabolite ratio in Caucasian smokersDetermination of Cotinine, 3′-Hydroxycotinine, and Their Glucuronides in Urine by Ultra-high Performance Liquid Chromatography
P2860
Q33724160-43466A39-D198-4B7A-BB39-24CCE28C5E76Q34434951-1264C056-1909-4BA3-8541-B480C9C05F8BQ34926339-0881EDB6-DA94-4679-A563-5FF1BF126D12Q34963910-23975679-1617-4A4C-98CC-9DABB44A4A86Q34964392-413113C2-0C36-4988-9FBD-AFF04A53A9DBQ35099123-22E0025D-BAAB-4AED-A10E-9A07FFD4EB1BQ35319092-E9C86FA4-CF9E-4131-9083-9EF2CD4A7BE9Q35534291-48EE9EEA-149F-4860-B84E-6CEDE033D336Q35691825-3530E668-FBAC-44F5-BD47-2D0A02065815Q35745357-6506690C-695F-4D6D-86E7-0D6DB785E947Q35908239-565CA0F1-7A54-4981-8B24-2586150FEADCQ36340552-24710208-5759-4419-92F1-926E9AF25646Q36527546-BD07D145-7415-4EF3-B7FB-936A65629033Q36940755-4EB32D7B-45C3-443B-8BC8-5174DC56E20EQ37056893-2972F09C-02C0-421C-AC36-5781E61A887BQ37163230-15E54AE9-A91F-491F-8C26-9B12C5654EA7Q37381909-6FB2952F-D837-4288-9AE0-860D93DCBBCAQ37603906-6CC687B0-702A-493E-B424-78505974BF91Q37663398-43CA2E77-6627-4112-B46C-10899DADA988Q37700687-12D8079B-D385-48B0-BB0E-C1F82875BCCCQ38261875-5C8BCF39-9667-4FEA-8838-9896DDAC5E82Q38669817-0F6EF350-CB8D-4E53-8170-82B5E5059719Q38769425-C1A779C8-BE3F-46A2-8391-3C3FDEC101D3Q43585637-61040740-4D38-42DA-9622-5B3703A41436Q46424430-EBC4603F-92D6-4EF5-9441-4BB656F4E764Q50222452-9C02F111-4A81-4966-9849-D2B10D10E68CQ57710071-138B3E60-14AC-4E38-B84A-5EE87DCEB0DEQ57710078-05B72100-AA57-45EC-B69B-307805A8BAF9
P2860
Glucuronidation genotypes and nicotine metabolic phenotypes: importance of functional UGT2B10 and UGT2B17 polymorphisms
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Glucuronidation genotypes and ...... 2B10 and UGT2B17 polymorphisms
@ast
Glucuronidation genotypes and ...... 2B10 and UGT2B17 polymorphisms
@en
Glucuronidation genotypes and ...... 2B10 and UGT2B17 polymorphisms
@nl
type
label
Glucuronidation genotypes and ...... 2B10 and UGT2B17 polymorphisms
@ast
Glucuronidation genotypes and ...... 2B10 and UGT2B17 polymorphisms
@en
Glucuronidation genotypes and ...... 2B10 and UGT2B17 polymorphisms
@nl
prefLabel
Glucuronidation genotypes and ...... 2B10 and UGT2B17 polymorphisms
@ast
Glucuronidation genotypes and ...... 2B10 and UGT2B17 polymorphisms
@en
Glucuronidation genotypes and ...... 2B10 and UGT2B17 polymorphisms
@nl
P2093
P2860
P1433
P1476
Glucuronidation genotypes and ...... 2B10 and UGT2B17 polymorphisms
@en
P2093
Carla J Gallagher
Joshua E Muscat
Nino E Giambrone
Philip Lazarus
P2860
P304
P356
10.1158/0008-5472.CAN-09-4582
P407
P577
2010-09-28T00:00:00Z